CNS Neoplasm
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| HyperArc Registry Study (NCT05270707) | Varian, a Siemens Healthineers Company | 2022-03-31 |
| Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors (NCT04023669) | St. Jude Children's Research Hospital | 2019-08-08 |
Track CNS Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.